Related references
Note: Only part of the references are listed.SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma
Scott M. Schuetze et al.
CANCER (2016)
Imatinib in advanced chordoma: A retrospective case series analysis
Nadia Hindi et al.
EUROPEAN JOURNAL OF CANCER (2015)
Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma
Dae-Hee Lee et al.
PLOS ONE (2015)
Activation of the Akt-mTOR Pathway and Receptor Tyrosine Kinase in Patients With Solitary Fibrous Tumors
Yuichi Yamada et al.
CANCER (2014)
Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis
Daniel Pink et al.
ONCOLOGY (2014)
Phase II study on lapatinib in advanced EGFR-positive chordoma
S. Stacchiotti et al.
ANNALS OF ONCOLOGY (2013)
GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study
A. Italiano et al.
ANNALS OF ONCOLOGY (2013)
Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
J. G. van Oosterwijk et al.
BRITISH JOURNAL OF CANCER (2013)
Cediranib for Metastatic Alveolar Soft Part Sarcoma
Shivaani Kummar et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Role of Palliative Chemotherapy in Advanced Epithelioid Sarcoma
Robin L. Jones et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2012)
Sunitinib malate in solitary fibrous tumor (SFT)
S. Stacchiotti et al.
ANNALS OF ONCOLOGY (2012)
Phase II Study of Imatinib in Advanced Chordoma
Silvia Stacchiotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Epithelioid sarcoma: one institution's experience with a rare sarcoma
Angela A. Guzzetta et al.
JOURNAL OF SURGICAL RESEARCH (2012)
Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect
S. Stacchiotti et al.
ANNALS OF ONCOLOGY (2011)
Activity of Temozolomide and Bevacizumab in the Treatment of Locally Advanced, Recurrent, and Metastatic Hemangiopericytoma and Malignant Solitary Fibrous Tumor
Min S. Park et al.
CANCER (2011)
Alveolar Soft Part Sarcoma: Clinical Presentation, Treatment, and Outcome in a Series of 33 Patients at a Single Institution
Elisabetta Pennacchioli et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Hagop Kantarjian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment
Yvonne M. Schrage et al.
CANCER RESEARCH (2009)
Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
George D. Demetri et al.
CLINICAL CANCER RESEARCH (2009)
Prognostic Factors for Survival in Patients with Epithelioid Sarcoma: 441 Cases from the SEER Database
Muhammad Umar Jawad et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2009)
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria
Haesun Choi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma
R Chugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
